Gerber Kawasaki Founding Partner Hatem Dhiab:
"I think it actually was better than feared. I think everyone expected worse and we got relatively. You know in line or or better numbers and I think that it's it's funny how markets work. "
A retreat in bond yields helped big cap tech stocks extend their rebound this week, but cyclical stocks also rallied.
The Dow rose a modest 38 points. The S&P 500 and Nasdaq added about a quarter percent.
Healthcare stocks were the biggest drag on the S&P. Biogen shares dropped almost 7% after the U.S. government's Medicare program said it will limit access to its Alzheimer treatment, Aduhelm, to patients who are enrolled in a clinical trial. Shares of Eli Lilly also fell because it is developing similar drugs.
It'll be "remote first" for workers at Robinhood Markets. The online trading platform plans to move a majority of its employees to remote work on a permanent basis. That announcement failed to lift its beleaguered shares.
